Literature DB >> 12629243

Risk factors for fever in the neurologic intensive care unit.

Christopher Commichau1, Nikolaos Scarmeas, Stephan A Mayer.   

Abstract

OBJECTIVE: To identify risk factors for fever among patients treated in a neurologic intensive care unit (NICU).
METHODS: The authors prospectively studied the frequency and causes of fever, defined as a patient's first temperature > or =101 degrees F (38.3 degrees C), among 387 patients consecutively admitted to their NICU. After identifying risk factors for 1) any fever, 2) infectious fever, and 3) unexplained fever using logistic regression, they calculated disease-specific adjusted odds ratios for developing these types of fever among 12 diagnostic groups.
RESULTS: Fever occurred in 23% (87/387) of patients. Fifty-two percent of fevers were explained by infection (predominantly pneumonia or bronchitis), and 28% were unexplained despite a complete diagnostic evaluation. NICU length of stay was a risk factor for all three types of fever (all p < 0.004); other risk factors included depressed level of consciousness for any fever (p = 0.005) and infectious fever (p = 0.048), endotracheal intubation for infectious fever (p = 0.01), and intraventricular catheterization for unexplained fever (p = 0.004). Subarachnoid hemorrhage increased the risk of both infectious and unexplained fever, even after adjusting for these risk factors (p = 0.006).
CONCLUSION: Fever occurs in nearly 25% of NICU patients, and is associated with increased length of stay and depressed level of consciousness. Endotracheal intubation is a risk factor for infectious fever, whereas intraventricular catheterization is a risk factor for unexplained fever, which suggests a role for ventricular hemorrhage in the pathogenesis of "central" fever. Subarachnoid hemorrhage increases the risk of developing fever of all types.

Entities:  

Mesh:

Year:  2003        PMID: 12629243     DOI: 10.1212/01.wnl.0000047344.28843.eb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

Review 1.  Intracranial hemorrhage.

Authors:  Andrew M Naidech
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

2.  Intravascular cooling for fever control.

Authors:  Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

3.  Prospects for acute stroke-- what can intensive care medicine offer?

Authors:  Peter J D Andrews
Journal:  Intensive Care Med       Date:  2003-06-18       Impact factor: 17.440

4.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 5.  Fever management in SAH.

Authors:  V Scaravilli; G Tinchero; G Citerio
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

6.  Medical complications drive length of stay after brain hemorrhage: a cohort study.

Authors:  Andrew M Naidech; Bernard R Bendok; Paul Tamul; Sarice L Bassin; Charles M Watts; H Hunt Batjer; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2008-09-27       Impact factor: 3.210

7.  Clostridium difficile-associated disease acquired in the neurocritical care unit.

Authors:  S A Musa; H Robertshaw; S J Thomson; M L Cowan; T M Rahman
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

8.  Management of nosocomial external ventricular drain-related ventriculomeningitis.

Authors:  Ronny Beer; Bettina Pfausler; Erich Schmutzhard
Journal:  Neurocrit Care       Date:  2008-11-04       Impact factor: 3.210

9.  Current treatment options for intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.